Drug company GSK said Thursday the new antibiotic, called gepotidacin, works at least as well as nitrofurantoin, a current front-line medication used to treat UTIs. The company said it would follow a recommendation from its independent data monitoring committee to stop the study early because the drug had already proven to be effective. GSK said it would prepare its findings for publication in a medical journal and submit its data to the FDA for approval next year.
Another round will drop out between the second and third phase, typically because companies run out of funds to develop them. ” And so this is something that we’ve been dealing with, at the same time when there are increasing numbers of infections that are harder and harder to treat with the drugs that we do have.” Liu said getting marketing approval for gepotidacin was just the first hurdle.
This is surprising. Usually pharma isn’t interested in making drugs that are this effective. Because their business model is not to cure people of things, but rather to keep them just alive and functioning enough that they become repeat customers for however long they survive.
👏👏
Need to cashout on time
Drink water!!
Stop the massacres StopHazaraGenocide